12/13/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:02 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
8:54 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
4:00 PM | T2 Biosystems (Filer)
| Form PRE 14A | |
11/08/2024
8:30 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
8:01 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
11/06/2024
8:02 PM | JSAF Holdings, LLC (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
|
10/16/2024
3:59 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
7:59 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:00 PM | Elsbree David B (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:16 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
9:31 AM | Elsbree David B (Reporting)
T2 Biosystems (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
8:10 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:31 PM | T2 Biosystems (Filer)
| Form 424B5 | |
08/15/2024
7:26 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/15/2024
7:24 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
08/08/2024
3:49 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
07/29/2024
4:00 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/19/2024
3:16 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
11:15 PM | T2 Biosystems (Filer)
| Form EFFECT | |
05/24/2024
8:04 PM | T2 Biosystems (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2024
3:49 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:55 PM | T2 Biosystems (Filer)
| Form RW | |
05/14/2024
3:43 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:21 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/13/2024
5:19 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:29 PM | T2 Biosystems (Subject)
| Form FWP | |
05/07/2024
6:46 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D/A | |
05/07/2024
3:57 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
8:38 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
8:40 PM | T2 Biosystems (Subject)
| Form FWP | |
05/06/2024
4:19 PM | T2 Biosystems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
4:24 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
4:27 PM | T2 Biosystems (Filer)
| Form S-1/A | |
05/06/2024
6:48 AM | T2 Biosystems (Filer)
| Form S-1/A | |
04/22/2024
4:13 PM | T2 Biosystems (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/19/2024
3:31 PM | CR Group L.P. (Filed by)
T2 Biosystems (Subject)
| Form SC 13D | |
WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad) Warren Buffett has sold a staggering $97 billion worth of stocks this year...
But why?
Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash.
His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years. Take these 4 steps today to protect your retirement NOW |
04/16/2024
7:35 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:31 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:17 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
8:06 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
8:00 AM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:11 PM | New Dimensions Trading (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
03/11/2024
5:14 PM | Safier Jacob (Filed by)
T2 Biosystems (Subject)
| Form SC 13G | |
03/04/2024
3:34 PM | T2 Biosystems (Filer)
| Form DEF 14A | |
02/16/2024
4:17 PM | CR Group L.P. (Reporting)
CRG Partners III Unlev AIV I L.P. (0001767510) (Reporting)
CRG Partners III L.P. (Reporting)
T2 Biosystems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:47 PM | T2 Biosystems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:49 PM | T2 Biosystems (Filer)
| Form PRE 14A | |
02/13/2024
7:15 PM | Lind Global Fund II LP (Filed by)
T2 Biosystems (Subject)
| Form SC 13G/A | |
